No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 3.6x · 10Y median 8.0x · 9th percentile · as of Sep 11, 2026
Annualized revenue (TTM) · by quarter, last 27
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-09-30T10:51:24.696Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-09-30T10:51:24.696Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-09-30T10:51:24.696Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-09-30T10:51:24.696Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-09-30T10:51:24.696Z. Latest historical point 2026-09-11.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-09-30T10:51:24.696Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-30T10:51:24.696Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-30T10:51:24.696Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for nCino, Inc. (NCNO) stock was $17.95 as of Sep 29, 2026, 4:00 PM EDT, down 3.49% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -30.3% · 3-year avg -12.3%/yr · 5-year avg -22.1%/yr
nCino, Inc. operates as a software-as-a-service (SaaS) provider, delivering cloud-based applications to financial organizations both within the United States and internationally.
Software - Application · Wilmington, NC
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Dec 2, 2026
63 days away
EPS Estimate
0.33
Revenue Est.
$162.58M
Last Quarter Results
EPS
$0.26
vs Estimate
$0.27
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1NCNO | $1.97B | $17.95 | -3.49% | -30.25% | -22.12% | N/A | N/A |
| 2ASAN | $1.96B | $8.23 | -4.75% | -36.47% | -38.23% | N/A | vs NCNO |
| 3QUBT | $1.90B | $8.46 | -1.28% | -49.74% | +4.18% | +44.57% | vs NCNO |
| 4SHAZ | $1.90B | $54.17 | +2.38% | N/A | N/A | N/A | vs NCNO |
| 5ICHR | $2.08B | $59.76 | +0.57% | +234.68% | +5.48% | N/A | vs NCNO |
| 6KEEL | $2.16B | $3.58 | -0.56% | +75.07% | -8.51% | N/A | vs NCNO |
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$161.00M
vs Estimate
$159.14M
Consensus Rating
Based on 11 analysts
Average Price Target
$24.27
+35.2% upside
Low
$17.00
Current
$17.95
High
$28.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $0.32 | $0.33 | $0.35 | 9 |
| Quarter ending Jan 2027 | $0.32 | $0.34 | $0.36 | 8 |
| Quarter ending Apr 2027 | $0.38 | $0.39 | $0.39 | 4 |
| Quarter ending Jul 2027 | $0.38 | $0.38 | $0.38 | 3 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $1.29 | $1.31 | $1.32 | 7 |
| FY 2028 | $1.47 | $1.57 | $1.64 | 8 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $162.47M | $162.58M | $162.71M | 8 |
| Quarter ending Jan 2027 | $162.68M | $163.09M | $163.97M | 8 |
| Quarter ending Apr 2027 | $171.35M | $171.76M | $172.46M | 5 |
| Quarter ending Jul 2027 | $173.57M | $173.98M | $174.70M | 4 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $645.37M | $646.13M | $647.05M | 10 |
| FY 2028 | $694.46M | $701.18M | $705.76M | 10 |
